German biotech company Proteros has announced significant changes in its management team. Michael Grau has joined Proteros as Chief Financial Officer, succeeding Arnd Christ whose duties Mr Grau will now assume with immediate effect. In addition, Dr Peter Reinemer, longstanding member of the Proteros management team, was promoted to Chief Operating Officer.
Mr Grau, MBA, joined Proteros from US healthcare company Correvio, where he served since 2011 as Group Chief Financial Officer and Chief Compliance Officer. Over the last 15 years Mr Grau has held senior management positions in several leading international Biotech and Medtech companies in Germany and Switzerland. Previously, he held management positions within Warner Bros and Paramount Pictures. Prior to this he spent several years with KPMG.
Mr Grau holds a BA in European Finance & Accounting from the Leeds and Bremen University and an Executive MBA from the Henley Management School, London.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze